Additionally, improving CAR-T biological efficiency could reduce dosing needs, further cutting costs and expanding access.

Clinical trials of Utjefra, Russia’s first CAR-T development, started in Russia in 2024. As Olga Alyoshina, Head of the Department of Cellular and Immune Therapy at the National Research Medical ...

Welcome to Money, Sky News' consumer and financial news hub. Today: interest rate forecasts have changed after a drop in inflation; and the best mobile providers have been ranked after a large UK ...

AbbVie has been involved in the development of the switchable CAR-T platform since 2018, when it licensed the technology for various tumour targets in return for an undisclosed upfront fee.

Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy investigated in the ZUMA-1 trial – is the first chimeric antigen receptor (CAR) T-cell therapy recommended for ...

Today, the Jericho Lands is a pretty sleepy place. Wedged on a 36-hectare plot of land between an oceanfront park and one of Vancouver’s least-populated and most-expensive neighbourhoods, the property ...

The Best of Car Talk America's funniest auto mechanics take calls from weary car owners all over the country, and crack wise while they diagnose Dodges and dismiss Diahatsus.

The IAEA Milestones Approach enables a sound development process for a nuclear power programme. It is a phased comprehensive method to assist countries that are considering or planning their first ...

What to know about borrowing for a car If you can’t or don’t want to pay cash for ... you will pay less in interest. This process is called amortization. Auto loan calculators and car payment ...

NEW DELHI: On a day Mumbai terror attack accused Tahawwur Hussain Rana was extradited from the US to India, Congress said Modi govt did not initiate the process and ...

Does the Kia Syros emerge as the new benchmark for safety among sub-4m SUVs in India? Let’s compare it with the Mahindra XUV 3XO using Bharat NCAP results. With over 20,000 unit sales since its ...